National Health Investors Inc (NHI) Stock Analysis
Verdict: HOLD
Resilient 5.2% yield and superior margins are currently overshadowed by a negative earnings surprise trend and technical breakdown.
Investment score: 62/100
Analysis as of
Is National Health Investors Inc stock worth reviewing? The TradeMates thesis
NHI offers a defensive yield backed by strong gross margins, but technical weakness and earnings disappointments demand patience until the $67.94 floor is tested and held.
7-factor investment score
- Valuation: 55/100 (weight 20%)
- Financial Health: 72/100 (weight 15%)
- Technical Momentum: 35/100 (weight 15%)
- Earnings Quality: 40/100 (weight 15%)
- Insider Sentiment: 50/100 (weight 10%)
- Analyst Consensus: 80/100 (weight 10%)
- Risk-Adjusted Return: 75/100 (weight 15%)
National Health Investors Inc opportunities and risks
What speaks for NHI
- Attractive Relative Valuation
What speaks against NHI
- Ongoing Earnings Underperformance
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| NHI | 23.2x | 8.6x | 16.2x | 61.3% | 36.8% | 6.6% |
| ARE | n/a | 3.1x | 52.8x | 68.2% | -35.3% | 15.6% |
| CTRE | 24.6x | 18.6x | 19.0x | 73.8% | 71.5% | 4.5% |
| JAN | n/a | 6.2x | 18.6x | 100.0% | -7.9% | 0.3% |
| HR | n/a | 6.2x | 21.2x | -8.6% | -17.3% | 1.9% |
| SBRA | 29.8x | 5.7x | 15.5x | 63.5% | 19.2% | 7.9% |
| Peer median | n/a | 6.2x | 19.0x | 68.2% | -7.9% | 4.5% |
Frequently asked questions about National Health Investors Inc (NHI)
Is NHI stock a good investment?
The TradeMates model rates National Health Investors Inc as HOLD with an investment score of 62/100. NHI offers a defensive yield backed by strong gross margins, but technical weakness and earnings disappointments demand patience until the $67.94 floor is tested and held. This is algorithmic model output, not personal investment advice.
Is NHI stock a buy?
The TradeMates model verdict for NHI is HOLD with an investment score of 62/100. Treat this as a model signal to review, not a personal buy recommendation.